122 related articles for article (PubMed ID: 9930583)
1. Plasma glicentin in diabetic and gastrectomized patients.
Naito H; Ohneda A; Kojima R; Sato T; Sasaki K; Funayama Y; Fukushima K; Shibata C; Matsuno S; Sasaki I
Regul Pept; 1999 Jan; 79(1):55-61. PubMed ID: 9930583
[TBL] [Abstract][Full Text] [Related]
2. Effect of intraluminal administration of amino acids upon plasma glicentin.
Ohneda A; Kobayashi T; Nihei J; Takahashi H
Diabetes Res Clin Pract; 1988 Oct; 5(4):265-70. PubMed ID: 3069408
[TBL] [Abstract][Full Text] [Related]
3. Response of plasma glicentin to intraduodenal administration of glucose in piglets.
Ohneda A
Diabetes Res Clin Pract; 1987; 3(2):97-102. PubMed ID: 3568997
[TBL] [Abstract][Full Text] [Related]
4. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.
Miholic J; Orskov C; Holst JJ; Kotzerke J; Meyer HJ
Dig Dis Sci; 1991 Oct; 36(10):1361-70. PubMed ID: 1914756
[TBL] [Abstract][Full Text] [Related]
5. Postnatal and postprandial changes in plasma concentrations of glicentin in term and preterm infants.
Tadokoro R; Shimizu T; Hosaka A; Kaneko N; Satoh Y; Yamashiro Y
Acta Paediatr; 2003 Oct; 92(10):1175-9. PubMed ID: 14632334
[TBL] [Abstract][Full Text] [Related]
6. Insulinotropic action of human glicentin in dogs.
Ohneda A; Ohneda K; Nagasaki T; Sasaki K
Metabolism; 1995 Jan; 44(1):47-51. PubMed ID: 7854165
[TBL] [Abstract][Full Text] [Related]
7. Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs.
Ohneda A; Kobayashi T; Nihei J
Diabetologia; 1986 Jun; 29(6):397-401. PubMed ID: 3527839
[TBL] [Abstract][Full Text] [Related]
8. Response of plasma glicentin to fat ingestion in piglets.
Ohneda A; Takahashi H; Maruyama Y
Diabetes Res Clin Pract; 1987; 3(2):103-9. PubMed ID: 3552536
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
Herrmann C; Göke R; Richter G; Fehmann HC; Arnold R; Göke B
Digestion; 1995; 56(2):117-26. PubMed ID: 7750665
[TBL] [Abstract][Full Text] [Related]
10. Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas.
Ohneda A; Ohneda M
Tohoku J Exp Med; 1988 Jun; 155(2):197-204. PubMed ID: 3062845
[TBL] [Abstract][Full Text] [Related]
11. A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon-derived peptide levels.
Kobayashi M; Maruyama N; Yamamoto Y; Togawa T; Ida T; Yoshida M; Miyazato M; Kitada M; Hayashi Y; Kashiwagi A; Kitamura T
J Diabetes Investig; 2023 May; 14(5):648-658. PubMed ID: 36729958
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of glucagon-like polypeptides in patients with esophagoplasty.
Tamburrano G; Lala A; Mauceri M; Tonelli F; Leonetti F; Andreani D
J Endocrinol Invest; 1982; 5(2):107-9. PubMed ID: 6896521
[TBL] [Abstract][Full Text] [Related]
13. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
14. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
Kervran A; Blache P; Bataille D
Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
[TBL] [Abstract][Full Text] [Related]
15. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
Manell H; Staaf J; Manukyan L; Kristinsson H; Cen J; Stenlid R; Ciba I; Forslund A; Bergsten P
J Clin Endocrinol Metab; 2016 Mar; 101(3):1181-9. PubMed ID: 26745255
[TBL] [Abstract][Full Text] [Related]
16. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
Blache P; Kervran A; Bataille D
Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
Drucker DJ; Asa SL; Silverberg J; Brubaker PL
Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
[TBL] [Abstract][Full Text] [Related]
18. Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy.
Andreasen JJ; Orskov C; Holst JJ
Digestion; 1994; 55(4):221-8. PubMed ID: 8063025
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
Hiroyoshi M; Tateishi K; Yasunami Y; Maeshiro K; Ono J; Matsuoka Y; Ikeda S
Am J Gastroenterol; 1999 Apr; 94(4):976-81. PubMed ID: 10201468
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
